glp-1 news 2025 october 16 Trends: Access & Shortages, Insurance Coverage & More GLP-1 trends 2025: real-world data,

The combination therapy option is particularly effective for long-term weight maintenance

This distinction is critical because it means compounded products have not been evaluated by the FDA for safety, effectiveness, or quality in the same manner as FDA-approved drugs

The briefing was held 1 day after the publication of a white paper authored by the Center for Medicine in the Public Interest that criticized the FDA for not doing enough to crack down on illegal GLP-1 compounding and provided recommendations calling for greater enforcement of existing FDA regulations

Understanding these genetic insights helps PlexusDx clinicians select the optimal compound and dosing strategy, potentially reducing overall side-effect burden and improving injection tolerance

Like any medication, GLP-1 injections can have side effects, though most are mild and temporary

Ibsen S, Schutt CE, Esener S